Skip to main content

Advertisement

Log in

Conjugated and Entrapped HPMA-PLA Nano-Polymeric Micelles Based Dual Delivery of First Line Anti TB Drugs: Improved and Safe Drug Delivery against Sensitive and Resistant Mycobacterium Tuberculosis

  • Research Paper
  • Published:
Pharmaceutical Research Aims and scope Submit manuscript

Abstract

Purpose

First line antiTB drugs have several physical and toxic manifestations which limit their applications. RIF is a hydrophobic drug and has low water solubility and INH is hepatotoxic. The main objective of the study was to synthesize, characterize HPMA-PLA co-polymeric micelles for the effective dual delivery of INH and RIF.

Methods

HPMA-PLA co-polymer and HPMA-PLA-INH (HPI) conjugates were synthesized and characterized by FT-IR and 1H–NMR spectroscopy. Later on RIF loaded HPMA-PLA-INH co-polymeric micelles (PMRI) were formulated and characterized for size, zeta potential and surface morphology (SEM, TEM) as well as critical micellar concentration. The safety was assessed through RBC’s interaction study. The prepared PMRI were evaluated through MABA assay against sensitive and resistant strains of M. Tuberculosis.

Results

Size, zeta and entrapment efficiency for RIF loaded HPMA-PLA-INH polymeric micelles (PMRI) was 87.64 ± 1.98 nm, −19 ± 1.93 mV and 97.2 ± 1.56%, respectively. In vitro release followed controlled and sustained delivery pattern. Sustained release was also supported by release kinetics. Haemolytic toxicity of HPI and PMRI was 8.57 and 7.05% (p < 0.01, INH Vs PMRI; p < 0.0001, RIF Vs PMRI), respectively. MABA assay (cytotoxicity) based MIC values of PMRI formulation was observed as ≥0.0625 and ≥0.50 μg/mL (for sensitive and resistant strain). The microscopic analysis further confirmed that the delivery approach was effective than pure drugs.

Conclusions

RIF loaded and INH conjugated HPMA-PLA polymeric micelles (PMRI) were more effective against sensitive and resistant M tuberculosis. The developed approach can lead to improved patient compliance and reduced dosing in future, offering improved treatment of tuberculosis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7

Similar content being viewed by others

Abbreviations

Ar:

Aromatic

CMC:

Critical micelle concentration

DCC:

N,N′-dicyclohexylcarbodiimide

DCM:

Dichloromethane

EDC:

N-(3-dimethylaminopropyl)-N′-ethylcarbodiimide

ETH:

Ethambutol

HPI:

HPMA-PLA-INH conjugates

HPMA:

N(2-hydroxypropyl) methacrylamide

INH:

Isoniazid

MDR-TB:

Multidrug-resistant TB

PLA:

Poly lactic acid

PMRI:

RIF loading in HPMA-PLA-INH conjugates

PYZ:

Pyrazinamide

RIF:

Rifampicin

SEM:

Scanning electron microscopy and

TB:

Tuberculosis

TEM:

Transmission electron microscopy

References

  1. Mehanna MM, Mohyeldin SM, Elgindy NA. Respirable nanocarriers as a promising strategy for antitubercular drug delivery. J Control Release. 2014;187:183–97.

    Article  CAS  PubMed  Google Scholar 

  2. World Health Organization. Global Tuberculosis Report. 2015.

  3. Shah U, Jasani A. UV spectrophotometric and Rp-HPLC methods for simultaneous estimation of isoniazid, rifampicin and piperine in pharmaceutical dosage form. Int J Pharm Pharm Sci. 2014;6(10):274–80.

    Google Scholar 

  4. Rajan M, Raj V. Encapsulation, characterisation and in-vitro release of anti-tuberculosis drug using chitosan-poly ethylene glycol nanoparticles. Int J Pharm Pharm Sci. 2012;4(4):255–9.

    CAS  Google Scholar 

  5. Du Toit LC, Pillay V, Danckwerts MP. Tuberculosis chemotherapy: current drug delivery approaches. Respir Res. 2006;7:118.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Gandhi NR, Shah NS, Andrews JR, Vella V, Moll AP, Scott M, et al. Am J Respir Crit Care Med. 2010;181:80.

    Article  PubMed  Google Scholar 

  7. Solaro R, Chiellini F, Battisti A. Targeted delivery of protein drugs by nanocarriers. Materials. 2010;3:1928–80.

    Article  CAS  Google Scholar 

  8. Mourya VK, Inamdar N, Nawale RB, Kulthe SS. Polymeric micelles: general considerations and their applications. Ind J Pharm Edu Res. 2011;45(2):128–38.

    Google Scholar 

  9. Talelli M, Rijcken CJF, Van Nostrum CF, Storm G, Hennink WE. Micelles based on HPMA co-polymers. Adv Drug Deliv Rev. 2010;62:231–9.

    Article  CAS  PubMed  Google Scholar 

  10. Kwon GS, Okano T. Polymeric micelles as new drug carriers. Adv Drug Deliv Rev. 1996;21:107–16.

    Article  CAS  Google Scholar 

  11. Rapoport N. Physical stimuli-responsive polymeric micelles for anti-cancer drug delivery. Prog Polym Sci. 2007;32:962–90.

    Article  CAS  Google Scholar 

  12. Yokoyama M. Clinical applications of polymeric micelle carrier systems in chemotherapy and image diagnosis of solid tumors. J Exp Clin Med. 2011;3(4):151–8.

    Article  CAS  Google Scholar 

  13. Ulbricha K, Subra V, Strohalma J, Plocova D, Jelınkova M, Ihova BR. Polymeric drugs based on conjugates of synthetic and natural macromolecules synthesis and physico-chemical characterisation. J Control Release. 2000;64:63–79.

    Article  Google Scholar 

  14. Ma G, Zhang C, Zhang L, Sun H, Song C, Wang C, et al. Doxorubicin-loaded micelles based on multiarm star-shaped PLGA–PEG block copolymers: influence of arm numbers on drug delivery. J Mater Sci Mater Med. 2016;27(17):1–15.

    Google Scholar 

  15. Huang D, Li D, Wang T, Shen H, Zhao P, Liu B, et al. Isoniazid conjugated poly(lactide-co-glycolide): long-term controlled drug release and tissue regeneration for bone tuberculosis therapy. Biomaterials. 2015;52:417–25.

    Article  CAS  PubMed  Google Scholar 

  16. Wei Z, Hao J, Yuan S, Li Y, Juan W, Sha X, et al. Paclitaxel-loaded pluronic P123/F127 mixed polymeric micelles: formulation, optimization and in vitro characterization. Int J Pharm. 2009;376:176–85.

    Article  CAS  PubMed  Google Scholar 

  17. Gaucher G, Dufresne MH, Sant VP, Kang N, Maysinger D, Leroux JC. Block co-polymer micelles: preparation, characterization and application in drug delivery. J Control Release. 2005;109:169–88.

    Article  CAS  PubMed  Google Scholar 

  18. Khan I, Gothwal A, Sharma AK, Qayum A, Singh SK. Biodegradable nano-architectural PEGylated approach for the improved stability and anticancer efficacy of bendamustine. Int J Biol Macromol. 2016;92:1242–51.

    Article  CAS  PubMed  Google Scholar 

  19. Chen L, Xie Z, Hu J, Chen X, Jing X. Enantiomeric PLA–PEG block co-polymers and their stereocomplex micelles used as rifampin delivery. J Nanopart Res. 2007;9:777–85.

    Article  Google Scholar 

  20. Raza K, Kumar N, Misra C, Kaushik L, Guru SK, Kumar P, et al. Dextran-PLGA-loaded docetaxel micelles with enhanced cytotoxicity and better pharmacokinetic profile. Int J Biol Macromol. 2016;88:206–12.

    Article  CAS  PubMed  Google Scholar 

  21. Scarano W, Souza PD, Stenzel MH. Dual-drug delivery of curcumin and platinum drugs in polymeric micelles enhances the synergistic effects: a double act for the treatment of multidrug-resistant cancer. Biomater Sci. 2014;3:163–74.

    Article  PubMed  Google Scholar 

  22. Rajera R, Nagpal K, Singh SK, Mishra DN. Toxicological study of the Primaquine phosphate loaded chitosan nanoparticles in mice. Int J Biol Macromol. 2013;62:18–24.

    Article  CAS  PubMed  Google Scholar 

  23. Singhai AK, Jain S, Jain NK. Evaluation of an aqueous injection of Ketoprofen. Pharmazie. 1997;52:149–51.

    CAS  PubMed  Google Scholar 

  24. Franzblau SG, Witzig RS, Mclaughlin JC, Torres P, Madico G, Hernandez A, et al. Rapid, low-technology mic determination with clinical mycobacterium tuberculosis isolates by using the microplate alamar blue assay. J Clin Microbiol. 1998;36:362–6.

    CAS  PubMed  PubMed Central  Google Scholar 

  25. Huh KM, Lee SC, Cho YW, Lee J, Jeong JH, Park K. Hydrotropic polymer micelle system for delivery of paclitaxel. J Control Release. 2005;101:59–68.

    Article  CAS  PubMed  Google Scholar 

  26. Wu Y, Li M, Gao H. Polymeric micelle composed of PLA and chitosan as a drug carrier. J Polym Res. 2009;16:11–8.

    Article  CAS  Google Scholar 

  27. Moretton MA, Glisoni RJ, Chiappetta DA, Sosnik A. Molecular implications in the nanoencapsulation of the anti-tuberculosis drug rifampicin within flower-like polymeric micelles. Colloids Surf B. 2010;79:467–79.

    Article  CAS  Google Scholar 

  28. Singhvi G, Singh M. Review: in-vitro drug release characterization models. Int J Pharm Stu Res. 2011;2:77–84.

    Google Scholar 

  29. Gothwal A, Khan I, Gupta U. Polymeric micelles: recent advancements in the delivery of anticancer drugs. Pharm Res. 2016;33:18–39.

    Article  CAS  PubMed  Google Scholar 

  30. Gupta U, Sharma S, Khan I, Gothwal A, Sharma AK, Singh Y, et al. Enhanced apoptotic and anticancer potential of paclitaxel loaded biodegradable nanoparticles based on chitosan. Int J Biol Macromol. 2017;98:810–9.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Umesh Gupta.

Ethics declarations

Conflict of Interest

The authors declare no competing financial interest.

Electronic supplementary material

ESM 1

(DOCX 698 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Upadhyay, S., Khan, I., Gothwal, A. et al. Conjugated and Entrapped HPMA-PLA Nano-Polymeric Micelles Based Dual Delivery of First Line Anti TB Drugs: Improved and Safe Drug Delivery against Sensitive and Resistant Mycobacterium Tuberculosis . Pharm Res 34, 1944–1955 (2017). https://doi.org/10.1007/s11095-017-2206-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11095-017-2206-3

KEY WORDS

Navigation